Skip to main content

Articles

Page 2 of 4

  1. Central Diabetes Insipidus (CDI) results from decreased production of antidiuretic hormone (ADH) leading to an inability to concentrate urine. CDI is treated with desmopressin (DDAVP). Rarely reported in the l...

    Authors: Teresa E. Pinto, Arati Mokashi and Elizabeth A. Cummings
    Citation: Clinical Diabetes and Endocrinology 2021 7:11
  2. High Performance Liquid Chromatography (HPLC) technique is considered as a gold standard for HbA1c analysis however all laboratories cannot adopt it due to certain limitations. Our aim was to compare Particle ...

    Authors: Shabnam Dildar, Sheharbano Imran and Farah Naz
    Citation: Clinical Diabetes and Endocrinology 2021 7:10
  3. With the onset of the COVID-19 pandemic and state-mandated school closures in the spring of 2020, the management of type 1 diabetes in children underwent significant changes. The aim of our study was to assess...

    Authors: Miriannette Gayoso, Whei Ying Lim, Madhuri S. Mulekar and Anne-Marie D. Kaulfers
    Citation: Clinical Diabetes and Endocrinology 2021 7:9
  4. Severe insulin resistance is an uncommon finding in patients with type 2 diabetes but is often associated with difficult to managing blood glucose. While severe insulin resistance is most frequently seen in th...

    Authors: Alison H. Affinati, Amisha Wallia and Roma Y. Gianchandani
    Citation: Clinical Diabetes and Endocrinology 2021 7:8
  5. Gestational Diabetes Mellitus (GDM) is associated with adverse health outcomes during pregnancy and beyond. Previous randomized controlled trials of exercise interventions have demonstrated that exercise, cond...

    Authors: Oluwafemifola Onaade, Jill M. Maples, Bethany Rand, Kimberly B. Fortner, Nikki B. Zite and Samantha F. Ehrlich
    Citation: Clinical Diabetes and Endocrinology 2021 7:7
  6. Hypopituitarism in the elderly population is an underdiagnosed condition and may increase comorbidities related to glucose metabolism, dyslipidemia, and cardiovascular risk factors. Optimization of hormone rep...

    Authors: Isabella Naves Rosa, Alexandre Anderson de Sousa Munhoz Soares, Marcelo Palmeira Rodrigues and Luciana Ansaneli Naves
    Citation: Clinical Diabetes and Endocrinology 2021 7:6
  7. The link between metabolic syndrome and depression has always been controversial. Different studies that have examined the relationship between metabolic syndrome and depression have reported different results...

    Authors: Yousef Moradi, Ahmed N Albatineh, Hassan Mahmoodi and Reza Ghanei Gheshlagh
    Citation: Clinical Diabetes and Endocrinology 2021 7:4
  8. The COVID-19 pandemic has rapidly changed the landscape of medical care and the healthcare system needs to quickly adapt in order to continue providing optimal medical care to hospitalized patients in an effic...

    Authors: Marcio L. Griebeler, Kevin M. Pantalone, Ron Gambino, David Shewmon, Jay Morrow, Daniel Mendlovic, Vinni Makin, Marwan Hamaty, Sana Hasan, M. Cecilia Lansang, Keren Zhou and Bartolome Burguera
    Citation: Clinical Diabetes and Endocrinology 2021 7:5
  9. Type 2 Diabetes is a metabolic disorder characterized by hyperglycemia that causes numerous complications with significant long-term morbidity and mortality. The disorder is primarily due to insulin resistance...

    Authors: Michael Albosta and Jesse Bakke
    Citation: Clinical Diabetes and Endocrinology 2021 7:3
  10. We intended to estimate the proportion hypoglycemic/hyperglycemic emergency episodes in treated diabetes mellitus (DM) patients admitted to a hospital ward, and calculate the prevalence of risk factors for hyp...

    Authors: Sílvia Alão, João Conceição, Jorge Dores, Lèlita Santos, Francisco Araújo, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana De Sousa Lages, João Pelicano-Romano and Paula M. de Jesus
    Citation: Clinical Diabetes and Endocrinology 2021 7:2
  11. Evidence suggests that insulin therapy of patients with type 2 diabetes mellitus (T2DM) is frequently discontinued. However, the reasons for discontinuing insulin and factors associated with insulin discontinu...

    Authors: Jianmin Wu, Fritha Morrison, Zhenxiang Zhao, Ginger Haynes, Xuanyao He, Ayad K. Ali, Maria Shubina, Shervin Malmasi, Wendong Ge, Xiaomei Peng and Alexander Turchin
    Citation: Clinical Diabetes and Endocrinology 2021 7:1
  12. The COVID-19 pandemic has prompted the rapid transition of in-person outpatient care to telemedicine, and clinical training to remote learning. The endocrinology fellows at the University of Michigan maintain ...

    Authors: Xin He, Daniel Shelden, Andrew Kraftson, Tobias Else and Richard J. Auchus
    Citation: Clinical Diabetes and Endocrinology 2020 6:25
  13. Acromegaly is associated with higher morbidity and mortality mainly due to cardiovascular disease. Data on the incidence and evolution of thyroid cancer in acromegaly are controversial. Our objective was to de...

    Authors: Karina Danilowicz, Soledad Sosa, Mariana Soledad Gonzalez Pernas, Elizabeth Bamberger, Sabrina Mara Diez, Patricia Fainstein-Day, Alejandra Furioso, Mariela Glerean, Mirtha Guitelman, Débora Katz, Nicole Lemaitre, Alicia Lowenstein, Mariela del Valle Luna, María Paz Martínez, Karina Miragaya, Daniel Moncet…
    Citation: Clinical Diabetes and Endocrinology 2020 6:24
  14. Central pontine myelinolysis (CPM) is a non-inflammatory demyelinating lesion of the pons. CPM and extrapontine demyelination (EPM) are together termed osmotic demyelination syndrome (ODS), a known and serious...

    Authors: Koshi Kusumoto, Nobuyuki Koriyama, Nami Kojima, Maki Ikeda and Yoshihiko Nishio
    Citation: Clinical Diabetes and Endocrinology 2020 6:23
  15. Diabetes mellitus (DM) is one of the most common chronic diseases. Individuals with DM are more likely to be hospitalised and stay longer than those without DM. Inpatient hypoglycemia and hyperglycemia, which ...

    Authors: Shih Ling Kao, Ying Chen, Yilin Ning, Maudrene Tan, Mark Salloway, Eric Yin Hao Khoo, E Shyong Tai and Chuen Seng Tan
    Citation: Clinical Diabetes and Endocrinology 2020 6:21
  16. The most common type of monogenic diabetes is maturity-onset diabetes of the young (MODY), a clinically and genetically heterogeneous group of endocrine disorders that affect 1–5% of all patients with diabetes...

    Authors: Ken Munene Nkonge, Dennis Karani Nkonge and Teresa Njeri Nkonge
    Citation: Clinical Diabetes and Endocrinology 2020 6:20
  17. While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the ...

    Authors: David R. Brown, Honey E. East, Bradley S. Eilerman, Murray B. Gordon, Elizabeth E. King, Laura A. Knecht, Brandon Salke, Susan L. Samson, Kevin C. J. Yuen and Hanford Yau
    Citation: Clinical Diabetes and Endocrinology 2020 6:18
  18. Diabetes mellitus with autosomal dominant inheritance, such as maturity-onset diabetes of the young (MODY), is a genetic form of diabetes mellitus. MODY is a type of monogenic diabetes mellitus in which multip...

    Authors: Juan Camilo Mateus, Carolina Rivera, Miguel O’Meara, Alex Valenzuela and Fernando Lizcano
    Citation: Clinical Diabetes and Endocrinology 2020 6:16
  19. To examine the clinical and hormonal profiles, comorbidities, treatment patterns, surgical pathology and clinical outcomes of patients diagnosed with acromegaly at the Cleveland Clinic over a 15-year period.

    Authors: Lima Lawrence, Kenda Alkwatli, James Bena, Richard Prayson, Varun Kshettry, Pablo Recinos, Betul Hatipoglu, Kevin M. Pantalone, Robert Weil, Amir H. Hamrahian, Laurence Kennedy and Divya Yogi-Morren
    Citation: Clinical Diabetes and Endocrinology 2020 6:15
  20. Psychosocial distress can act as a barrier to diabetes self-care management and thus compromise diabetes control. Yet in Ghana, healthcare centres mainly focus on the medical aspect of diabetes to the neglect ...

    Authors: Margaret Amankwah-Poku, Albert G. B. Amoah, Araba Sefa-Dedeh and Josephine Akpalu
    Citation: Clinical Diabetes and Endocrinology 2020 6:14
  21. Classical heterozygous pathogenic variants of the lamin A/C (LMNA) gene cause autosomal dominant familial partial lipodystrophy type 2 (FPLD2). However, recent reports indicate phenotypic heterogeneity among carr...

    Authors: Utku Erdem Soyaltin, Ilgin Yildirim Simsir, Baris Akinci, Canan Altay, Suleyman Cem Adiyaman, Kristen Lee, Huseyin Onay and Elif Arioglu Oral
    Citation: Clinical Diabetes and Endocrinology 2020 6:13
  22. Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome that presents with hypophosphatemia, bone pain, muscle weakness and fractures. We report a case series of four patients with TIO that resulted...

    Authors: Debbie W. Chen, Gregory A. Clines, Michael T. Collins, Liselle Douyon and Palak U. Choksi
    Citation: Clinical Diabetes and Endocrinology 2020 6:12
  23. Young adults with type 1 diabetes face potential health problems and disruptions in accessing care related to their move from pediatrics into adult care. At a medium-sized pediatric hospital with no formal tra...

    Authors: Sarah Williams, Leigh Anne Allwood Newhook, Heather Power, Rayzel Shulman, Sharon Smith and Roger Chafe
    Citation: Clinical Diabetes and Endocrinology 2020 6:11
  24. Obstructive sleep apnea syndrome (OSAS) in association with Type 2 Diabetes Mellitus (DM) may result in increased glycemic variability affecting the glycemic control and hence increasing the risk of complicati...

    Authors: Suhas S. Khaire, Jugal V. Gada, Ketaki V. Utpat, Nikita Shah, Premlata K. Varthakavi and Nikhil M. Bhagwat
    Citation: Clinical Diabetes and Endocrinology 2020 6:10
  25. Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by the lack of adipose tissue and metabolic complications with predominantly autosomal recessive inheritance. There are 6 different g...

    Authors: Ekaterina Sorkina, Polina Makarova, Liubov Bolotskaya, Irina Ulyanova, Tatyana Chernova and Anatoly Tiulpakov
    Citation: Clinical Diabetes and Endocrinology 2020 6:7
  26. Thyroid ultrasound is usually used to risk-stratify incidental thyroid nodules. Nodules with high risk sonographic features for malignancy are evaluated by fine-needle aspiration. The role of core needle biops...

    Authors: Noura Nachawi, Madelyn Lew, Kristine Konopka and Zahrae Sandouk
    Citation: Clinical Diabetes and Endocrinology 2020 6:6
  27. This study evaluated the impact of atherosclerotic cardiovascular disease (ASCVD) on healthcare resource utilization and costs in patients with type 2 diabetes mellitus (T2DM).

    Authors: Wayne Weng, Ye Tian, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett and Todd Hobbs
    Citation: Clinical Diabetes and Endocrinology 2020 6:5
  28. It was highlighted that the original article [1] contained an error regarding the nomenclature in the gene described.

    Authors: Juan Carlos Lizarzaburu-Robles, Juan Carlos Gomez-de-la-Torre, María del Carmen Castro-Mujica, Flor Vento, Sofia Villanes, Elizabeth Salsavilca and Chris Guerin
    Citation: Clinical Diabetes and Endocrinology 2020 6:4

    The original article was published in Clinical Diabetes and Endocrinology 2020 6:3

  29. Prevalence of maturity-onset diabetes of the young (MODY) is estimated between 1 and 2% of all diabetes cases. In Latin-America little information has been described about the frequency of the disease, perhaps...

    Authors: Juan Carlos Lizarzaburu-Robles, Juan Carlos Gomez-de-la-Torre, María del Carmen Castro-Mujica, Flor Vento, Sofia Villanes, Elizabeth Salsavilca and Chris Guerin
    Citation: Clinical Diabetes and Endocrinology 2020 6:3

    The Correction to this article has been published in Clinical Diabetes and Endocrinology 2020 6:4

  30. To examine the impact on glycemic control of achieving postprandial glucose (PPG) target with lixisenatide, a once-daily glucagon-like peptide-1 receptor agonist approved in the US, in patients with uncontroll...

    Authors: Jaime A. Davidson, William Stager, Sachin Paranjape, Rachele Berria and Lawrence A. Leiter
    Citation: Clinical Diabetes and Endocrinology 2020 6:2
  31. The programmed cell death 1 (PD-1) inhibitor pembrolizumab is a promising agent for treatment of several different malignancies, but as with all immunotherapy there is a potential risk of immune-related advers...

    Authors: Sho Tanaka, Masaru Kushimoto, Tsukasa Nishizawa, Masahiro Takubo, Kazutaka Mitsuke, Jin Ikeda, Midori Fujishiro, Katsuhiko Ogawa, Ichiro Tsujino, Yutaka Suzuki and Masanori Abe
    Citation: Clinical Diabetes and Endocrinology 2020 6:1
  32. Diabetes mellitus continues to be a rising concern in the United States. It affects an estimated 9.4% of the population and approximately 1.5 million Americans are diagnosed annually. Approximately 85% of diab...

    Authors: Christine Jarocki, Brian M. Schmidt and Crystal Murray Holmes
    Citation: Clinical Diabetes and Endocrinology 2019 5:14
  33. The heterozygous microdeletion of chromosome 22q11.2 results in a spectrum of disorders, including DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS), with phenotypic features that can include the cl...

    Authors: Raad A. Haddad, Gregory A. Clines and Jennifer A. Wyckoff
    Citation: Clinical Diabetes and Endocrinology 2019 5:13
  34. Pitfalls in hormonal assays are commonly seen in clinical practice and may lead to erroneous clinical impressions and treatments. In this article, we address common laboratory pitfalls encountered during evalu...

    Authors: Raad A. Haddad, Donald Giacherio and Ariel L. Barkan
    Citation: Clinical Diabetes and Endocrinology 2019 5:12
  35. American Diabetes Association (ADA) sets annual guidelines on preventative measures that aim to delay the onset of severe diabetes mellitus complications. Compared to private internal medicine clinics, residen...

    Authors: Subhash Edupuganti, Jordan Bushman, Rhyan Maditz, Pradeep Kaminoulu and Alexandra Halalau
    Citation: Clinical Diabetes and Endocrinology 2019 5:11
  36. The major published clinical guidelines for the management of hypothyroidism and osteoporosis are not uniformly consistent and may be a significant contributor to variability of clinical care delivered by endo...

    Authors: Jien Shim, Tiffany Lin, Cody Dashiell-Earp, Meghan Nechrebecki and Angela M. Leung
    Citation: Clinical Diabetes and Endocrinology 2019 5:10
  37. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) is a rare syndrome with unknown etiology. Metabolic abnormalities are not known to be part of the syndro...

    Authors: Abdel Wahab Jalal Eldin, Dilara Tombayoglu, Laura Butz, Alison Affinati, Rasimcan Meral, Mehmet Selman Ontan, Kelly Walkovich, Maria Westerhoff, Jeffrey W. Innis, Neehar D. Parikh and Elif A. Oral
    Citation: Clinical Diabetes and Endocrinology 2019 5:9
  38. The presentation of Kaposi sarcoma is divided into four known clinical subtypes. In this case report we describe classic Kaposi sarcoma in an African-American heterosexual, diabetic, seronegative human immunod...

    Authors: Garneisha M. Torrence and James S. Wrobel
    Citation: Clinical Diabetes and Endocrinology 2019 5:8
  39. Insulin delivery triggered by a remote control is an advanced feature offered by newer insulin pump systems. These remote-integrated pump systems might further improve glycemic control and patient satisfaction...

    Authors: Asma Deeb, Mariette Akle, Layla Abdulrahman, Hana Suwaidi, Samar Awad and Sareea Remeithi
    Citation: Clinical Diabetes and Endocrinology 2019 5:7
  40. Diabetic retinopathy is the most common cause of blindness in working-age adults. Characteristics of patients with diabetes presenting to a retina subspecialty clinic have not been adequately studied, limiting...

    Authors: Nish Patel, Lilia Verchinina, Michele Wichorek, Thomas W. Gardner, Dorene Markel, Jennifer Wyckoff and Anjali R. Shah
    Citation: Clinical Diabetes and Endocrinology 2019 5:6
  41. Metreleptin, a recombinant methionyl -human -leptin, was approved to treat patients with generalized lipodystrophy (GL) in February 2014. However, leptin therapy has been associated with the development of lym...

    Authors: Nazanene H. Esfandiari, Melvyn Rubenfire, Adam H. Neidert, Rita Hench, Abdelwahab Jalal Eldin, Rasimcan Meral and Elif A. Oral
    Citation: Clinical Diabetes and Endocrinology 2019 5:4
  42. For adolescents and emerging adults, the transition from pediatrics to adult care is fraught with challenges both inside and outside the clinical arena, including assuming independent care for diabetes, workin...

    Authors: Jennifer Iyengar, Inas H. Thomas and Scott A. Soleimanpour
    Citation: Clinical Diabetes and Endocrinology 2019 5:3
  43. Globally, the burden of diabetes mellitus has increased to epidemic proportions. Estimates from the International Diabetes Federation predict that the greatest future increase in the prevalence of diabetes mel...

    Authors: Davis Kibirige, William Lumu, Angus G. Jones, Liam Smeeth, Andrew T. Hattersley and Moffat J. Nyirenda
    Citation: Clinical Diabetes and Endocrinology 2019 5:2
  44. Since 2011 six immune checkpoint inhibitors (ICI) have been approved to treat patients with many advanced solid tumor and hematological malignancies to improve their prognosis. Case reports of their endocrine ...

    Authors: Meng H. Tan, Ravi Iyengar, Kara Mizokami-Stout, Sarah Yentz, Mark P. MacEachern, Li Yan Shen, Bruce Redman and Roma Gianchandani
    Citation: Clinical Diabetes and Endocrinology 2019 5:1

Annual Journal Metrics

  • Speed 2023
    Submission to first editorial decision (median days): 55
    Submission to acceptance (median days): 198

    Usage 2023
    Downloads: 339,787
    Altmetric mentions: 189